Wilson Sonsini - ECP

insight detail

Wilson Sonsini Advises 1859, Inc. on Launch and $40 Million Series A

  • 02/06/22
  • Client Highlights
  • Life Sciences
  • Medical Devices
  • Biotech

ECP Attorneys:

Copyright © 2022 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.